`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`APOTEX INC., APOTEX CORP., and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners
`
` v.
`
`NOVARTIS AG,
`Patent Owner
`
`
`
`Case IPR2017-008541
`U.S. Patent No. 9,187,405
`
`
`PATENT OWNER’S LIST OF PROPOSED MOTIONS
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`August 23, 2017
`
` 1 Case IPR2017-01550 has been joined with this proceeding.
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to the Patent Trial and Appeal Board’s Office Patent Trial Practice
`
`Guide, and in advance of the initial conference call scheduled for Friday, August 25,
`
`2017 at 1 PM, Patent Owner Novartis AG hereby provides a list of the proposed
`
`motions it presently anticipates filing in the above-captioned inter partes review
`
`(“IPR”) proceeding. Patent Owner has not listed those motions which are
`
`automatically authorized by the Board, such as motions to exclude evidence. The
`
`“[s]ubmission of [this] list [does] not preclude the filing of additional motions not
`
`contained in the list.” See 77 Fed. Reg. 48,756, 48,765 (Aug. 14, 2012).
`
`
`
`List of Proposed Motions
`
`1. A motion to amend the claims of the ’405 Patent pursuant to 37 C.F.R. §
`
`42.121.
`
`2. A motion for a protective order and motion(s) to seal confidential
`
`information pursuant to 37 C.F.R. § 42.54.
`
`3. A motion to extend Patent Owner’s word limits pursuant to 37 C.F.R. §
`
`42.24(a)(2).
`
`4. A motion to terminate Ground 3 as outside of 35 U.S.C. § 311 limiting
`
`institution of an inter partes review to “a ground that could be raised under
`
`
`
`
`
`
`
`
`
`
`
`
`
`section 102 or 103 and only on the basis of prior art consisting of patents
`
`or printed publications.”
`
`5. A motion to dismiss this proceeding as violating the U.S. Constitution by
`
`seeking to extinguish private property rights through a non-Article III
`
`forum without a jury or a fair opportunity to be heard, or alternatively a
`
`motion to stay this proceeding pending the outcome of review by the U.S.
`
`Supreme Court of the Oil States Energy Services, LLC v Greene’s Energy
`
`Group LLC, cert. granted (from IPR2014-00215) case.
`
`Respectfully Submitted,
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D., Reg. No. 42,812
`Lead Counsel for Patent Owner
`GIBSON, DUNN & CRUTCHER LLP
`200 Park Avenue
`New York, NY 10166
`Jlove@gibsondunn.com
`Tel.: 212-351-3922
`Dated: August 23, 2017
`
`2
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 4.26, the undersigned hereby certifies that a true
`
`and correct copies of Patent Owner’s List of Proposed Motions was served by
`
`email upon Petitioner’s counsel of record:
`
`For Apotex:
`
`Steven W. Parmelee: sparmelee@wsgr.com
`Michael T. Rosato: mrosato@wsgr.com
`Jad. A. Mills: jmills@wsgr.com
`
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`Telephone: 206-883-2542
`
`For Argentum:
`
`Teresa Stanek Rea: trea@crowell.com
`Deborah H. Yellin: dyelling@crowell.com
`Shannon M. Lentz: slentz@crowell.com
`Tyler C. Liu: TLiu@agpharm.com
`
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`Washington, DC 20004-2595
`(202) 624-2620
`via electronic mail and secure file transfer, pursuant to agreement of the parties, on
`
`the date hereof.
`
`
`
`3
`
`
`
`
`
`
`
`
`
`
`
`Dated: August 23, 2017
`
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D., Reg. No. 42,812
`Lead Counsel for Patent Owner
`GIBSON, DUNN & CRUTCHER LLP
`200 Park Avenue
`New York, NY 10166
`Jlove@gibsondunn.com
`Tel.: 212-351-3922
`Dated: August 23, 2017
`
`
`4
`
`
`
`